Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Therapeutic Trial of Intralesional Bevacizumab in Patients With Non-pedunculated Keloids

NCT01408953 is registered in ClinicalTrials.gov with Tirgan, Michael H., M.D. as lead sponsor.

NCT NCT01408953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01408953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Therapeutic Trial of Intralesional Bevacizumab in Patients With Non-pedunculated Keloids
Lead sponsor
Tirgan, Michael H., M.D.
Phase
Phase 2
Overall status
Terminated
Start date
February 29, 2012
Completion date
November 30, 2012
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keloid